unknown
Stage
2019
Founded
3
Investors
About
ImmunOs Therapeutics AG is a biotechnology company that develops HLA-based immunotherapies and human immunomodulatory proteins for cancer and autoimmune diseases. The company uses an HLA-driven platform to generate biologic therapeutics intended to engage innate and adaptive immunity and remodel the tumor microenvironment.
Explore ImmunOs Therapeutics AG's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.